NINLARO(ixazomib capsules) UK Website

 

NINLARO is licensed in combination with lenalidomide and dexamethasone for the treatment of adults with multiple myeloma who have received at least one prior therapy.

This website has been developed by Takeda Oncology and contains product and prescribing information intended for UK healthcare professionals. In addition, the site contains specific information for patients prescribed NINLARO. General information on multiple myeloma for the general public is also included.

Adverse events should be reported. In the United Kingdom, reporting forms and information can be found at https://yellowcard.mhra.gov.uk/.

Adverse events should also be reported to Takeda on 01628 537900 or e-mail DSO-UK@takeda.com.